Tag Archives: in vivo study

Atelocollagen-conjugated miR-520d-5p is effective dramatically in therapy-resistant undifferentiated cancers

We have previously shown that hsa-miR-520d-5p can convert cancer cells into induced pluripotent stem cells (iPSCs) or mesenchymal stem cells (MSCs) via the demethylation and consequent upregulation of TP53 in vivo. We have also reported that miR-520d-5p